The California governor’s pivot to the center may be too late for 2028.

NVE Corporation (NASDAQ:NVEC) Q3 2026 Earnings Call Transcript January 21, 2026 Daniel Baker: Good afternoon, and welcome to ...

An article from The Banker archives, republished to celebrate our 100th anniversary. Find out more ...

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Scientific progress devoid of moral reflection risks repeating past injustices ...

Guam Regional Medical City said it reached a groundbreaking milestone in Guam’s health care system on Sept. 16 with the successful implementation of continuous renal replacement therapy, a specialized ...

French prog rockers Esthesis, who won Pro g's Best Unsigned Band category in the 2020 Readers' Poll, recently released their ...